News & Updates

Patients with brain metastasis from gynaecologic cancers often present with an advanced stage disease and have had at least one prior recurrence, according to a study. In addition, the presence of an extracranial disease is common at the time of brain metastasis diagnosis.

Adding dostarlimab, an immune checkpoint inhibitor, to standard-of-care chemotherapy significantly improves progression-free survival (PFS) in patients with primary advanced or recurrent endometrial cancer, including those with dMMR-MSI-H* disease, according to the first interim analysis of the ENGOT-EN6-NSGO/GOG-3031/RUBY trial presented at SGO 2023.

Taking nutritional supplements before and throughout pregnancy puts children at lower risk of rapid weight gain and high body mass index, according to data from the NiPPeR trial.

The use of gemcitabine concurrently with cisplatin and intensity-modulated radiation therapy appears to improve response and prolong progression-free survival in women with locally advanced vulvar cancer not amenable to surgical resection, according to the results of the phase II NRG Oncology Trial 279 (NRG-GOG-0279) presented at SGO 2023.

Symptoms of sexual dysfunction (SD) normally occur during pregnancy, according to a study, noting the need for further research, particularly on validated tools that assess pregnancy-specific SD symptoms.

The minimally invasive high-intensity focused ultrasound (HIFU) appears to be beneficial in the treatment of women with uterine fibroids, significantly reducing fibroid volume and improving symptoms without increasing the frequency of postoperative complications.